AAAAAA
Results:
1-12
|
Results: 12
Authors:
Leroy, V
De Traversay, C
Barnoud, R
Hartmann, JD
Baud, M
Ouzan, D
Zarski, JP
Citation: V. Leroy et al., Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha, J HEPATOL, 35(1), 2001, pp. 120-126
Authors:
Halfon, P
Trimoulet, P
Bourliere, M
Khiri, H
de Ledinghen, V
Couzigou, P
Feryn, JM
Alcaraz, P
Renou, C
Fleury, HJA
Ouzan, D
Citation: P. Halfon et al., Hepatitis C virus genotyping based on 5 ' noncoding sequence analysis (Trugene), J CLIN MICR, 39(5), 2001, pp. 1771-1773
Authors:
Ouzan, D
Pesle, B
Baldini, E
Rimbourg, H
Darphin, F
Cohen, N
Brichetti, A
Follana, R
Citation: D. Ouzan et al., Anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region, GASTRO CL B, 24(3), 2000, pp. 337-341
Authors:
Ouzan, D
Collomp, R
Mousnier, A
Citation: D. Ouzan et al., What happens to the needles, syringes, vials and pens after interferon injections at home?, GASTRO CL B, 24(10), 2000, pp. 966-967
Authors:
Hausfater, P
Cacoub, P
Rosenthal, E
Bernard, N
Loustaud-Ratti, V
Le Lostec, Z
Laurichesse, H
Turpin, F
Ouzan, D
Grasset, D
Perrone, C
Cabrol, MP
Piette, J
Citation: P. Hausfater et al., Hepatitis C virus infection and lymphoproliferative diseases in France: A national study, AM J HEMAT, 64(2), 2000, pp. 107-111
Authors:
Halfon, P
Halimi, G
Bourliere, M
Ouzan, D
Durant, J
Khiri, H
Mercier, L
Gerolami, V
Cartouzou, G
Citation: P. Halfon et al., Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy, LIVER, 20(5), 2000, pp. 381-386
Authors:
Tran, A
Longo, F
Ouzan, D
Bianchi, D
Pradier, C
Saint-Paul, MC
Sattonnet, C
Laffont, C
Dantin, S
Piche, T
Benzaken, S
Rampal, P
Citation: A. Tran et al., Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity, SC J GASTR, 35(4), 2000, pp. 433-437
Authors:
Ouzan, D
Citation: D. Ouzan, Risk of hepatitis C virus transmission during digestive tract endoscopy, PRESSE MED, 28(20), 1999, pp. 1091-1094
Authors:
Halfen, P
Bourliere, M
Feryn, JM
Khiri, H
Chanas, M
Salvadori, JM
Ouzan, D
Citation: P. Halfen et al., Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients, J HEPATOL, 30(3), 1999, pp. 552-552
Authors:
Mercier, B
Barclais, A
Botte, C
Cantalube, JF
Coste, J
Defer, C
Gautreau, C
Giannoli, C
Halfon, P
Lepot, I
Loiseau, P
Martial, J
Montcharmont, P
Merel, P
Ouzan, D
Ravera, N
Follana, J
Cesaire, R
Janot, C
Lemaire, JM
De Micco, P
Vezon, G
Ferec, C
Citation: B. Mercier et al., Prevalence of GBV C HGV RNA and GBV C HGV antibodies in French volunteer blood donors: Results of a collaborative study, VOX SANGUIN, 76(3), 1999, pp. 166-169
Authors:
Gugenheim, J
Baldini, E
Ouzan, D
Sowka, P
Mouiel, J
Citation: J. Gugenheim et al., Good results of lamivudine in hepatitis B surface antigen-positive patients with active viral replication before liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 554-555
Authors:
Baldini, E
Gugenheim, J
Ouzan, D
Katkhouda, N
Mouiel, J
Citation: E. Baldini et al., Orthotopic liver transplantation with and without peritoneal drainage: A comparative study, TRANSPLAN P, 31(1-2), 1999, pp. 556-557
Risultati:
1-12
|